In this study we utilized apolipoprotein E-deficient (ApoE−/−) atherosclerosis mouse models to explore whether JC-5411 (PEITC formulation) has anti-atherosclerosis activity in vivo, and to ascertain the underlying mechanism of its action. The gene discussed is APOE; the disease is atherosclerosis.